Mechanisms of synergism between gemcitabine and cisplatin

Adv Exp Med Biol. 1998:431:581-5. doi: 10.1007/978-1-4615-5381-6_112.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / adverse effects
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antimetabolites, Antineoplastic / toxicity*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Cisplatin / adverse effects
  • Cisplatin / toxicity*
  • DNA, Neoplasm / biosynthesis
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Deoxycytidine / pharmacokinetics
  • Deoxycytidine / toxicity
  • Drug Synergism
  • Female
  • Gemcitabine
  • Humans
  • Ovarian Neoplasms
  • RNA, Neoplasm / biosynthesis
  • Tumor Cells, Cultured

Substances

  • Antimetabolites, Antineoplastic
  • DNA, Neoplasm
  • RNA, Neoplasm
  • Deoxycytidine
  • Cisplatin
  • Gemcitabine